| 31.03.2022 13:24 | NSCI | PDS Provides Business Update & Full-Year Results | RNS |
| 04.03.2022 07:30 | NSCI | Publication of Shareholder Newsletter | Reach |
| 24.02.2022 16:45 | NSCI | PDS Announces Preliminary Safety Data on PDS0101 | Reach |
| 15.02.2022 14:32 | NSCI | PDS Clinical Trial with Mayo Clinic | Reach |
| 02.02.2022 15:00 | NSCI | PDS Phase 2 Trial Update | Reach |
| 28.01.2022 08:45 | NSCI | PDS Announces Preclinical Data for PDS0202 Vaccine | Reach |
| 18.01.2022 07:00 | NSCI | Holding(s) in Company | RNS |
| 10.01.2022 14:20 | NSCI | PDS Granted Novel HPV16 Immunotherapy Patent | Reach |
| 10.01.2022 07:00 | NSCI | ProAxsis CEO End of Year Update | Reach |
| 29.12.2021 08:47 | NSCI | Issue of Equity | RNS |
| 21.12.2021 13:59 | NSCI | TR-1: Form for notification of major holdings | RNS |
| 21.12.2021 07:00 | NSCI | Q-Bot Investment and Share Acquisition | RNS |
| 20.12.2021 07:00 | NSCI | Acquisition of majority stake in Cetromed | RNS |
| 13.12.2021 07:00 | NSCI | Martlet Capital Update | RNS |
| 06.12.2021 14:53 | NSCI | PDS Phase 2 Clinical Trial Update | RNS |
| 26.11.2021 07:00 | NSCI | $1million investment in portfolio company, EpiBone | Reach |
| 10.11.2021 13:58 | NSCI | PDS Reports Q3 2021 Results & Business Update | RNS |
| 04.11.2021 07:00 | NSCI | Sofant Signs EUR7.3m ESA Contract | Reach |
| 01.11.2021 14:16 | NSCI | PDS to License Novel Proteins for Flu Vaccine | Reach |
| 26.10.2021 07:00 | NSCI | EMV Capital Participates in £843k Sofant Funding | Reach |
| 22.10.2021 11:18 | NSCI | ProAxsis announces the approval of a key US patent | Reach |
| 22.10.2021 09:04 | NSCI | Holding(s) in Company | RNS |
| 21.10.2021 16:40 | NSCI | Second Price Monitoring Extn | RNS |
| 21.10.2021 16:35 | NSCI | Price Monitoring Extension | RNS |
| 21.10.2021 14:17 | NSCI | PDS Phase 2 Clinical Trial Update | RNS |
| 05.10.2021 07:00 | NSCI | PDS Phase 2 Clinical Trial Update | Reach |
| 04.10.2021 07:00 | NSCI | Investor Presentations | Reach |
| 30.09.2021 10:22 | NSCI | Holding(s) in Company | RNS |
| 29.09.2021 07:00 | NSCI | Grant of Options to Directors | RNS |
| 29.09.2021 07:00 | NSCI | Interim Results | RNS |
| 20.09.2021 07:00 | NSCI | Notice of Results and Analyst Briefing | RNS |
| 16.09.2021 07:00 | NSCI | Investment in Martlet Capital Limited | RNS |
| 09.08.2021 17:59 | NSCI | Holding(s) in Company | RNS |
| 30.07.2021 09:12 | NSCI | Holding(s) in Company | RNS |
| 26.07.2021 16:25 | NSCI | Holding(s) in Company | RNS |
| 22.07.2021 16:29 | NSCI | Holding(s) in Company | RNS |
| 20.07.2021 14:05 | NSCI | Second Price Monitoring Extn | RNS |
| 20.07.2021 14:00 | NSCI | Price Monitoring Extension | RNS |
| 16.07.2021 10:35 | NSCI | Director/PDMR Shareholding | RNS |
| 01.07.2021 12:08 | NSCI | Holding(s) in Company | RNS |
| 30.06.2021 15:42 | NSCI | Holding(s) in Company | RNS |
| 30.06.2021 10:29 | NSCI | Holding(s) in Company | RNS |
| 30.06.2021 10:27 | NSCI | Holding(s) in Company | RNS |
| 28.06.2021 15:18 | NSCI | Result of General Meeting, TVR & PDMR Dealings | RNS |
| 22.06.2021 07:00 | NSCI | PDS Announces Closing of c. $52m Public Offering | Reach |
| 16.06.2021 07:00 | NSCI | NSCI Participates in $45m PDS Equity Issue | RNS |
| 15.06.2021 07:00 | NSCI | PDS announces proposed offering of common stock | RNS |
| 10.06.2021 12:56 | NSCI | Result of Placing and Total Voting Rights | RNS |
| 10.06.2021 07:00 | NSCI | Proposed Placing | RNS |
| 09.06.2021 16:40 | NSCI | Second Price Monitoring Extn | RNS |
| 09.06.2021 16:35 | NSCI | Price Monitoring Extension | RNS |
| 09.06.2021 14:05 | NSCI | Second Price Monitoring Extn | RNS |
| 09.06.2021 14:00 | NSCI | Price Monitoring Extension | RNS |
| 08.06.2021 16:36 | NSCI | Price Monitoring Extension | RNS |
| 08.06.2021 13:40 | NSCI | PDS Announces Release of PDS0101 Interim Data | RNS |
| 08.06.2021 11:05 | NSCI | Second Price Monitoring Extn | RNS |
| 08.06.2021 11:00 | NSCI | Price Monitoring Extension | RNS |
| 07.06.2021 16:40 | NSCI | Second Price Monitoring Extn | RNS |
| 07.06.2021 16:35 | NSCI | Price Monitoring Extension | RNS |
| 07.06.2021 14:06 | NSCI | Second Price Monitoring Extn | RNS |
| 07.06.2021 14:00 | NSCI | Price Monitoring Extension | RNS |
| 07.06.2021 07:00 | NSCI | ProAxsis Update | RNS |
| 03.06.2021 16:30 | NSCI | Result of AGM | RNS |
| 03.06.2021 08:14 | NSCI | Holding(s) in Company | RNS |
| 28.05.2021 14:20 | SDR, NSCI | Holding(s) in Company | RNS |
| 27.05.2021 16:41 | NSCI | Second Price Monitoring Extn | RNS |
| 27.05.2021 16:36 | NSCI | Price Monitoring Extension | RNS |
| 24.05.2021 07:00 | NSCI | ProAxsis Update | Reach |
| 21.05.2021 11:00 | NSCI | Price Monitoring Extension | RNS |
| 20.05.2021 16:19 | NSCI | PDS Announces Release of PDS0101 Abstract | RNS |
| 20.05.2021 07:00 | NSCI | EMV Capital Advises on £3.4m PointGrab Fundraise | Reach |
| 18.05.2021 07:00 | NSCI | PDS receives $4.5m from net sale of tax benefits | RNS |
| 13.05.2021 15:15 | NSCI | PDS Reports Results for Q1 2021 & Business Update | Reach |
| 13.05.2021 07:00 | NSCI | EMV Capital Advises on £2.9m SageTech Fundraise | Reach |
| 30.04.2021 07:00 | NSCI | PDS Announces Presentation at ASCO Annual Meeting | RNS |
